معرفی
Dr Vaishnavi Nathan is a Clinical Research Coordinator at Frazer Institute and holds a PhD in Medical Genetics from The University of Queensland. Her research focuses on genetic predispositions to melanoma and other cancers, with particular attention to telomere maintenance genes (e.g., POT1), BRCA1/2, and albinism-related genes. She leads multidisciplinary collaborations across international consortia including GenoMEL and MelaNostrum, advancing understanding of familial cancer syndromes.
Her work bridges clinical and translational research, addressing genotype-phenotype correlations in melanoma subtypes and developing evidence-based genetic testing guidelines. Recent studies include analyses of spitzoid morphology in familial melanoma, UV radiation signatures in uveal tumors, and the impact of germline variants on cancer predisposition.
Dr Nathan has contributed to over 15 peer-reviewed publications since 2016, including high-impact journals like Nature Communications and Journal of Clinical Investigation. Her doctoral thesis (2021) established methodologies for functional assessment of melanoma susceptibility genes, forming the foundation for her ongoing research.
